July 25, 2014 6:40 AM ET


Company Overview of Biopure Corporation

Company Overview

Biopure Corporation went out of business. Biopure Corporation offers oxygen-carrying biological drugs called oxygen therapeutics. Oxygen therapeutics are intravenously administered to deliver oxygen to the body’s tissues. Its products include Hemopure, a human drug, for use in adult surgery patients who are acutely anemic and for eliminating, delaying, or reducing allogenic red blood cell transfusions in these patients; and Oxyglobin, a veterinary drug for the treatment of anemia in dogs. Hemopure is approved for sale in South Africa. The company focuses to market Hemopure to hospitals and pre-hospital environments; and sells Oxyglobin through distributors in the United States and Europe. Bi...

11 Hurley Street

Cambridge, MA 02141-2110

United States

Founded in 1984

4 Employees





Key Executives for Biopure Corporation

Biopure Corporation does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Discgenics, Inc. United States
ProteinOne United States
GE Healthcare Inc. United States
GeneWize Life Sciences, Inc. United States
CytoVale Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Biopure Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.